Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alvaro, Danza"'
Autor:
Graciela S Alarcón, Eduardo Kerzberg, Rosana Quintana, Guillermo Pons-Estel, Guillermo Berbotto, Veronica Saurit, Eloisa Bonfa, Loreto Massardo, Ana Malvar, Francinne Machado Ribeiro, Carlos Abud-Mendoza, Bernardo Pons-Estel, Manuel F Ugarte-Gil, Fernando Cavalcanti, Federico Zazzetti, Miguel A Saavedra, Urbano Sbarigia, Oscar Neira, Marina Scolnik, Alvaro Danza, Mercedes García, Ignacio Garcia-De La Torre, Romina Nieto, Cecilia Pisoni, Sabrina Porta, Anne Stevens, Eduardo Borba, Paula Alba, Vicente Juarez, Graciela Gomez, Carlos Enrique Toro Gutierrez, Luis Humberto Silveira Torre, Odirlei Monticielo, Nílzio Da Silva, Jorge Antonio Esquivel Valerio, Rosa Maria Serrano Morales, Lucia Hernández, Verónica Inés Bellomio, Gustavo Aroca Martínez, Andrés Cadena Bonfanti, Gerardo Quintana Lopez, Mario Javier Moreno Alvarez, Isabel Acosta-Colman, Astrid Paats, Claudia Mora, Diana Fernández Ávila, Carmen Funes Soaje, Edgard Reis Neto, Iris Guerra Herrera, Carlos Cañas, Margarita Portela, Hilda Fragoso Loyo, Armando Calvo Quiroz, Roberto Muñoz Louis, Ricardo Robaina, Ashley Orillion
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/698a3d31f8484bfba6f73d091096b678
Publikováno v:
Revista médica de Chile. 150:1317-1324
Publikováno v:
Lupus. 31:880-884
Objectives We aimed to study the daily dose of glucocorticoids in the first month associated with damage after 5 years of systemic lupus erythematosus (SLE) diagnosis; and to assess the daily dose of prednisone during the first year, over which damag
Autor:
Sabrina, Porta, Alvaro, Danza, Maira, Arias Saavedra, Adriana, Carlomagno, María Cecilia, Goizueta, Florencia, Vivero, Guillermo, Ruiz-Irastorza
Publikováno v:
Journal of Clinical Medicine
Since the discovery of glucocorticoids (GCs), their important anti-inflammatory effect, rapid mechanism of action, low cost, and accessibility have made them one of the mainstays of treatment for Systemic lupus erythematosus (SLE). Although their use
Publikováno v:
Medicina Clínica. 147:306-312
Systemic autoimmune diseases especially affect young women during childbearing age. The aim of this review is to update systemic lupus erythematosus, antiphospholipid syndrome and systemic sclerosis management during pregnancy. These diseases present
Publikováno v:
Medicina Clínica (English Edition). 147:306-312
Systemic autoimmune diseases especially affect young women during childbearing age. The aim of this review is to update systemic lupus erythematosus, antiphospholipid syndrome and systemic sclerosis management during pregnancy. These diseases present
Publikováno v:
Current opinion in rheumatology. 30(5)
The purpose of this review is highlighting the most recent evidence on the clinical efficacy and toxicity of glucocorticoids and antimalarials in systemic lupus erythematosus (SLE) and provide recommendations on their current use.Glucocorticoid toxic
Publikováno v:
Medicina Clínica. 141:533-542
Systemic lupus erythematosus (SLE) is a complex disease with different clinical forms of presentation, including a wide range of severity and organic involvement. Such circumstance, along with the fact of the uncommon nature of the disease and the ab
Autor:
Alvaro Danza, Guillermo Ruiz-Irastorza
Publikováno v:
Scopus-Elsevier
Infection is one of the leading causes of morbidity and mortality in systemic lupus erythematosus (SLE). Bacterial infections are most frequent, followed by viral and fungal infections. The impaired cellular and humoral immune functions seen in patie